LCN2 and COVID-19: Following Can et al.’s finding that neutrophil gelatinase-associated lipocalin is associated with the severity of COVID-19 in pregnant patients [81], the molecule has been regarded as an excellent biomarker for diagnosing the severity of COVID-19 in individuals with the disease.